FIELD: medicine, biotechnology, medicinal microbiology, pediatrics. SUBSTANCE: strain Bifidobacterium infantis 37 B (VKPM Ac-1636) is isolated from digestive tract of one year old health infant. The strain is able to inhibit the growth of opportunistic microorganism effectively and shows good acid- forming capacity and natural resistance to some antibiotics. The strain is non-pathogenic, apyrogenic for humans and animals and able to normalize digestive tract microflora in children. The strain is ready to usage in pediatric practice as biologically active supplements. Invention can be used for correction of disorders in microbiocenosis of digestive tract in children as biologically active supplements. EFFECT: valuable medicinal properties of strain. 3 tbl
Authors
Dates
2003-09-27—Published
2001-12-27—Filed